Reports
Global Binge Eating Disorder Market: By Treatment: Medication, Services; By Distribution Channel: Retail Pharmacy, Hospital Pharmacy, Online Pharmacy; Regional Analysis; Historical Market and Forecast (2018-2028); Market Dynamics: SWOT Analysis, Porter’s Five Forces Analysis; Competitive Landscape; Industry Events and Developments
Global Binge Eating Disorder Market Outlook
The global binge eating disorder market is expected to grow at a CAGR of 8.0% during the period 2023-2028. North America, Europe and Asia are expected to be key markets.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Global Market Likely to be Driven by Growing Awareness and Increasing Number of Doctors Treating Binge Eating Disorder
Binge eating disorder (BED) is a very common eating disorder in the United States. It has been suggested that binge eating disorder affects approximately 2.8 million people in the USA. People with the condition consume excessive amounts of food in a single sitting. During periods of binging, these individuals experience a sense of loss of control over their eating. Such binging episodes are often followed by feelings of guilt or shame. Binge eating has been associated with being overweight and obese. However, it is possible to be obese and not have binge eating disorder. Individuals with eating disorders often suffer in silence. It is thus difficult to identify the number of people affected by these disorders. It has been reported that just three percent of adults in USA who fulfilled the criteria for binge eating disorder received a diagnosis from their doctor. It is thus suggested that several individuals with the disorder do not receive medical treatment.
Binge Eating Disorder is Most Prevalent Among Women; May Result in Several Health Issues
Binge eating disorder may be seen in across all age groups, races, and income levels, however, it seems most prevalent among women. Among men, it is the most common eating disorder. Symptoms of binge eating disorder include:
- Regularly consuming more food than most people would in one sitting.
- Experiencing binge eating episodes at least once a week for three months or more.
- Feeling out of control while eating.
In addition, people with binge eating disorder must exhibit at least three of the following symptoms:
- Eating very fast or beyond the point of feeling full.
- Experiencing negative feelings of shame, guilt, or remorse about binge eating.
- Eating a lot even when not hungry.
- Eating alone, particularly because of embarrassment of the amount of food being eaten.
Individuals with the disorder do not try to compensate for their binges with unhealthy actions, such as dietary restriction or fasting, excessive exercising, and purging via self-induced vomiting or laxative abuse.
Binge eating disorder may result in several health risks usually associated with obesity, including diabetes, high cholesterol, high blood-pressure, heart, disease, osteoarthritis, sleep apnoea, etc. Individuals with binge eating disorder may also experience anxiety, depression, low self-esteem, and other conditions that significantly affect quality of life.
Availability of Treatment Expected to Drive Market Growth
Treatment for binge eating disorder is available and recovery possible. Growing awareness around the disorder and an increased number of doctors trained in the treatment of binge eating disorder has made it easier for people to receive treatment. These factors are expected to drive global binge eating disorder market growth. Treatments may usually involve a combination of psychotherapy, psychiatric intervention, and proper nutrition.
Treatment goals include reducing binge eating and supporting the person to eat regular meals. It is also important to address other associated emotional factors such as anxiety, depression, and self-esteem.
Development of New Treatments Likely to Drive Market Growth
Leading companies are engaged in developing treatments for patients with binge eating disorder. Such developments are expected to boost the global binge eating disorder market.
For example, in 2022, Tonix Pharmaceuticals Holding Corp. a clinical-stage biopharmaceutical company, announced an agreement with Massachusetts General Hospital, to evaluate TNX-1900 in an investigator initiated Phase 2 clinical trial as a probable treatment for individuals with binge eating disorder. The Phase 2 clinical trial was expected to start in the second half of 2022. Oxytocin, a well-known natural hormone used therapeutically in particular other indications including as an i.v. medication for the induction of labour in pregnancy with a medical indication; the proprietary intranasal dosage form was expected to enhance its properties for use in the underserved population of patients suffering from binge eating disorder.
Market Segmentation
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
By treatment, the market is segmented into:
- Medication (further broken down by type as given below)
- Antidepressant
- Anticonvulsant
- Anti-obesity Medication
- Others
- Services (further broken down by type as given below)
- Inpatient
- Outpatient
By distribution channel, the market is classified into:
- Retail Pharmacy
- Hospital Pharmacy
- Online Pharmacy
By region, the market is divided into:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Key Industry Players in the Market
The report presents a detailed analysis of the following key players in the global binge eating disorder market, looking into their capacity, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
- Tonix Pharmaceuticals Holding Corp.
- Takeda Pharmaceutical Company Limited
- Chronos Therapeutics Limited
- Pyramid Healthcare Inc.
- VIVUS LLC.
- Others
The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2022 |
| Historical Period | 2018-2022 |
| Forecast Period | 2023-2028 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Treatment |
|
| Breakup by Distribution Channel |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Market Snapshot
6.1 Global
6.2 Region
7 Opportunities and Challenges in the Market
8 Global Binge Eating Disorder Market Analysis
8.1 Key Industry Highlights
8.2 Global Binge Eating Disorder Historical Market (2018-2022)
8.3 Global Binge Eating Disorder Market Forecast (2023-2028)
8.4 Global Binge Eating Disorder Market by Treatment
8.4.1 Medication
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2018-2022)
8.4.1.3 Forecast Trend (2023-2028)
8.4.1.4 Breakup by Type
8.4.1.4.1 Antidepressant
8.4.1.4.2 Anticonvulsant
8.4.1.4.3 Anti-obesity Medication
8.4.1.4.4 Others
8.4.2 Services
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2018-2022)
8.4.2.3 Forecast Trend (2023-2028)
8.4.2.4 Breakup by Type
8.4.2.4.1 Inpatient
8.4.2.4.2 Outpatient
8.5 Global Binge Eating Disorder Market by Distribution Channel
8.5.1 Retail Pharmacy
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2018-2022)
8.5.1.3 Forecast Trend (2023-2028)
8.5.2 Hospital Pharmacy
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2018-2022)
8.5.2.3 Forecast Trend (2023-2028)
8.5.3 Online Pharmacy
8.5.3.1 Market Share
8.5.3.2 Historical Trend (2018-2022)
8.5.3.3 Forecast Trend (2023-2028)
8.6 Global Binge Eating Disorder Market by Region
8.6.1 North America
8.6.1.1 Market Share
8.6.1.2 Historical Trend (2018-2022)
8.6.1.3 Forecast Trend (2023-2028)
8.6.2 Europe
8.6.2.1 Market Share
8.6.2.2 Historical Trend (2018-2022)
8.6.2.3 Forecast Trend (2023-2028)
8.6.3 Asia Pacific
8.6.3.1 Market Share
8.6.3.2 Historical Trend (2018-2022)
8.6.3.3 Forecast Trend (2023-2028)
8.6.4 Latin America
8.6.4.1 Market Share
8.6.4.2 Historical Trend (2018-2022)
8.6.4.3 Forecast Trend (2023-2028)
8.6.5 Middle East and Africa
8.6.5.1 Market Share
8.6.5.2 Historical Trend (2018-2022)
8.6.5.3 Forecast Trend (2023-2028)
9 North America Binge Eating Disorder Market Analysis
9.1 United States of America
9.1.1 Market Share
9.1.2 Historical Trend (2018-2022)
9.1.3 Forecast Trend (2023-2028)
9.2 Canada
9.2.1 Market Share
9.2.2 Historical Trend (2018-2022)
9.2.3 Forecast Trend (2023-2028)
10 Europe Binge Eating Disorder Market Analysis
10.1 United Kingdom
10.1.1 Market Share
10.1.2 Historical Trend (2018-2022)
10.1.3 Forecast Trend (2023-2028)
10.2 Germany
10.2.1 Market Share
10.2.2 Historical Trend (2018-2022)
10.2.3 Forecast Trend (2023-2028)
10.3 France
10.3.1 Market Share
10.3.2 Historical Trend (2018-2022)
10.3.3 Forecast Trend (2023-2028)
10.4 Italy
10.4.1 Market Share
10.4.2 Historical Trend (2018-2022)
10.4.3 Forecast Trend (2023-2028)
10.5 Others
11 Asia Pacific Binge Eating Disorder Market Analysis
11.1 China
11.1.1 Market Share
11.1.2 Historical Trend (2018-2022)
11.1.3 Forecast Trend (2023-2028)
11.2 Japan
11.2.1 Market Share
11.2.2 Historical Trend (2018-2022)
11.2.3 Forecast Trend (2023-2028)
11.3 India
11.3.1 Market Share
11.3.2 Historical Trend (2018-2022)
11.3.3 Forecast Trend (2023-2028)
11.4 ASEAN
11.4.1 Market Share
11.4.2 Historical Trend (2018-2022)
11.4.3 Forecast Trend (2023-2028)
11.5 Australia
11.5.1 Market Share
11.5.2 Historical Trend (2018-2022)
11.5.3 Forecast Trend (2023-2028)
11.6 Others
12 Latin America Binge Eating Disorder Market Analysis
12.1 Brazil
12.1.1 Market Share
12.1.2 Historical Trend (2018-2022)
12.1.3 Forecast Trend (2023-2028)
12.2 Argentina
12.2.1 Market Share
12.2.2 Historical Trend (2018-2022)
12.2.3 Forecast Trend (2023-2028)
12.3 Mexico
12.3.1 Market Share
12.3.2 Historical Trend (2018-2022)
12.3.3 Forecast Trend (2023-2028)
12.4 Others
13 Middle East and Africa Binge Eating Disorder Market Analysis
13.1 Saudi Arabia
13.1.1 Market Share
13.1.2 Historical Trend (2018-2022)
13.1.3 Forecast Trend (2023-2028)
13.2 United Arab Emirates
13.2.1 Market Share
13.2.2 Historical Trend (2018-2022)
13.2.3 Forecast Trend (2023-2028)
13.3 Nigeria
13.3.1 Market Share
13.3.2 Historical Trend (2018-2022)
13.3.3 Forecast Trend (2023-2028)
13.4 South Africa
13.4.1 Market Share
13.4.2 Historical Trend (2018-2022)
13.4.3 Forecast Trend (2023-2028)
13.5 Others
14 Market Dynamics
14.1 SWOT Analysis
14.1.1 Strengths
14.1.2 Weaknesses
14.1.3 Opportunities
14.1.4 Threats
14.2 Porter’s Five Forces Analysis
14.2.1 Supplier’s Power
14.2.2 Buyer’s Power
14.2.3 Threat of New Entrants
14.2.4 Degree of Rivalry
14.2.5 Threat of Substitutes
14.3 Key Indicators for Demand
14.4 Key Indicators for Price
15 Competitive Landscape
15.1 Market Structure
15.2 Company Profiles
15.2.1 Tonix Pharmaceuticals Holding Corp.
15.2.1.1 Company Overview
15.2.1.2 Product Portfolio
15.2.1.3 Demographic Reach and Achievements
15.2.1.4 Certifications
15.2.2 Takeda Pharmaceutical Company Limited
15.2.2.1 Company Overview
15.2.2.2 Product Portfolio
15.2.2.3 Demographic Reach and Achievements
15.2.2.4 Certifications
15.2.3 Chronos Therapeutics Limited
15.2.3.1 Company Overview
15.2.3.2 Product Portfolio
15.2.3.3 Demographic Reach and Achievements
15.2.3.4 Certifications
15.2.4 Pyramid Healthcare Inc.
15.2.4.1 Company Overview
15.2.4.2 Product Portfolio
15.2.4.3 Demographic Reach and Achievements
15.2.4.4 Certifications
15.2.5 VIVUS LLC.
15.2.5.1 Company Overview
15.2.5.2 Product Portfolio
15.2.5.3 Demographic Reach and Achievements
15.2.5.4 Certifications
15.2.6 Others
16 Key Trends and Developments in the Market
List of Key Figures and Tables
1. Global Binge Eating Disorder Market: Key Industry Highlights, 2018 and 2028
2. Global Binge Eating Disorder Historical Market: Breakup by Treatment (USD Million), 2018-2022
3. Global Binge Eating Disorder Market Forecast: Breakup by Treatment (USD Million), 2023-2028
4. Global Binge Eating Disorder Historical Market: Breakup by Distribution Channel (USD Million), 2018-2022
5. Global Binge Eating Disorder Market Forecast: Breakup by Distribution Channel (USD Million), 2023-2028
6. Global Binge Eating Disorder Historical Market: Breakup by Region (USD Million), 2018-2022
7. Global Binge Eating Disorder Market Forecast: Breakup by Region (USD Million), 2023-2028
8. North America Binge Eating Disorder Historical Market: Breakup by Country (USD Million), 2018-2022
9. North America Binge Eating Disorder Market Forecast: Breakup by Country (USD Million), 2023-2028
10. Europe Binge Eating Disorder Historical Market: Breakup by Country (USD Million), 2018-2022
11. Europe Binge Eating Disorder Market Forecast: Breakup by Country (USD Million), 2023-2028
12. Asia Pacific Binge Eating Disorder Historical Market: Breakup by Country (USD Million), 2018-2022
13. Asia Pacific Binge Eating Disorder Market Forecast: Breakup by Country (USD Million), 2023-2028
14. Latin America Binge Eating Disorder Historical Market: Breakup by Country (USD Million), 2018-2022
15. Latin America Binge Eating Disorder Market Forecast: Breakup by Country (USD Million), 2023-2028
16. Middle East and Africa Binge Eating Disorder Historical Market: Breakup by Country (USD Million), 2018-2022
17. Middle East and Africa Binge Eating Disorder Market Forecast: Breakup by Country (USD Million), 2023-2028
18. Global Binge Eating Disorder Market Structure
Key Questions Answered in the Report
The global binge eating disorder market is projected to grow at a CAGR of 8.0% between 2023 and 2028.
The major drivers of the market include the growing awareness, surge in healthcare expenditure, access to advanced and novel therapeutics, increasing incidence of obesity, and rise in social media influence.
Rise in prevalence of eating disorder and increasing number of doctors treating binge eating disorder are the key industry trends propelling the market's growth.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The various treatments for binge eating disorder in the market are medication and services. Medication is further broken down into antidepressant, anticonvulsant, and anti-obesity medication, among others, while services are divided into inpatient and outpatient.
The several distribution channels of the market are retail pharmacy, hospital pharmacy, and online pharmacy.
The major players in the industry are Tonix Pharmaceuticals Holding Corp., Takeda Pharmaceutical Company Limited, Chronos Therapeutics Limited, Pyramid Healthcare Inc., and VIVUS LLC., among others.
Analyst Review
The global binge eating disorder market was driven by the rise in prevalence of eating disorder in the historical period. Aided by the increasing incidence of obesity and increasing number of doctors treating binge eating disorder, the market is expected to grow at a CAGR of 8.0% in the forecast period of 2023-2028.
EMR's meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. The various treatments for binge eating disorder in the market are medication and services. Medication is further broken down into antidepressant, anticonvulsant, and anti-obesity medication, among others, while services are divided into inpatient and outpatient. The several distribution channels of the market are retail pharmacy, hospital pharmacy, and online pharmacy. The major regional markets for binge eating disorder are North America, Europe, the Asia Pacific, Latin America, the Middle East and Africa. The major players in the industry are Tonix Pharmaceuticals Holding Corp., Takeda Pharmaceutical Company Limited, Chronos Therapeutics Limited, Pyramid Healthcare Inc., and VIVUS LLC., among others.
EMR's research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable and help them remain ahead of their competition.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$1699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateSingle User License
$2799-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next Update
Five User License
$3999-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$4999-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Contact AnalystAny Question? Speak With An Analyst
Request SampleView A Sample
Request CustomisationDid You Miss Anything, Ask Now
Why Expert Market Research?Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
Similar Reports
NEWSLETTER